Delaware Adolescent Program, Inc. (DAPI) - Kent County — Camden, Delaware

Delaware Adolescent Program, Inc. (DAPI) - Kent County is a clinical research site located in Camden, Delaware, United States 19934.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Delaware Adolescent Program, Inc. (DAPI) - Kent County has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gender-based Violence, Intimate Partner Violence.

Sponsors: RTI International.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Camden

Browse all research sites in Delaware · View every site in Camden

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Delaware Adolescent Program, Inc. (DAPI) - Kent County?

Delaware Adolescent Program, Inc. (DAPI) - Kent County has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Delaware Adolescent Program, Inc. (DAPI) - Kent County conducted?

Delaware Adolescent Program, Inc. (DAPI) - Kent County has 1 clinical trials on record, with 1 currently active. Their work covers Gender-based Violence, Intimate Partner Violence.

Is Delaware Adolescent Program, Inc. (DAPI) - Kent County accredited by Crixeo Clinical Trials?

Delaware Adolescent Program, Inc. (DAPI) - Kent County has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Delaware Adolescent Program, Inc. (DAPI) - Kent County?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.